Revvity (RVTY) Total Liabilities (2010 - 2026)
Revvity's (RVTY) quarterly Total Liabilities came in at $4.8 billion in Q3 2026, little changed on a YoY basis from $4.8 billion in Q3 2025, and little changed quarter-over-quarter from $4.8 billion in Q2 2026.
Analysis
Revvity (RVTY) Total Liabilities (2010 - 2026) Analysis & Trends
Revvity (RVTY) has reported Total Liabilities for 17 consecutive years, with $4.8 billion the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Total Liabilities changed 0.22% year-over-year to $4.8 billion; the trailing twelve-month figure through Jul 2026 stood at $4.8 billion (changed 0.22% YoY), and the FY2025 full-year result was $4.9 billion, up 4.07% from the prior year.
- Total Liabilities held at $4.8 billion in Q3 2026 per RVTY's latest filing, from $4.8 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $7.9 billion in Q1 2022 and bottomed at $4.7 billion in Q1 2025.
- Historically, Total Liabilities has averaged $5.8 billion across 5 years, with a median of $5.6 billion in 2024.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities soared 86.03% in 2022, then fell 16.98% in 2024.
- Over 5 years, Total Liabilities stood at $6.8 billion in 2022, then dropped by 15.78% to $5.7 billion in 2023, then dropped by 16.98% to $4.7 billion in 2024, then climbed by 4.07% to $4.9 billion in 2025, then dropped by 2.05% to $4.8 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $4.8 billion, $4.8 billion, and $4.9 billion for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 60.49 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 39.78 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 6.60 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3.81 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 4.82 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 478.51 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 3.08 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 838.15 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 204.52 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 3.65 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 4.82 Bn |
| Apr 5, 2026 | 4.81 Bn |
| Dec 28, 2025 | 4.92 Bn |
| Sep 28, 2025 | 4.76 Bn |
| Jun 29, 2025 | 4.81 Bn |
| Mar 30, 2025 | 4.72 Bn |
| Dec 29, 2024 | 4.73 Bn |
| Sep 29, 2024 | 4.85 Bn |
| Jun 30, 2024 | 5.55 Bn |
| Mar 31, 2024 | 5.59 Bn |
| Dec 31, 2023 | 5.69 Bn |
| Oct 1, 2023 | 5.73 Bn |
| Jul 2, 2023 | 6.35 Bn |
| Apr 2, 2023 | 6.60 Bn |
| Jan 1, 2023 | 6.75 Bn |
| Oct 2, 2022 | 6.76 Bn |
| Jul 3, 2022 | 7.02 Bn |
| Apr 3, 2022 | 7.66 Bn |
| Jan 2, 2022 | 7.86 Bn |
| Oct 3, 2021 | 7.94 Bn |